AXL tyrosine kinase mediates escape from type II JAK2 inhibition in myeloproliferative neoplasms Meeting Abstract


Authors: Codilupi, T.; Szybinski, J.; Brkic, S.; Stivala, S.; Yang, J. L.; Ghosh, N.; Passweg, J. R.; Angelillo-Scherrer, A.; Dirnhofer, S.; Levine, R. L.; Koche, R.; Meyer, S. C.
Abstract Title: AXL tyrosine kinase mediates escape from type II JAK2 inhibition in myeloproliferative neoplasms
Meeting Title: 5th Swiss Oncology and Hematology Congress (SOHC)
Journal Title: Swiss Medical Weekly
Volume: 152
Issue: Suppl. 265
Meeting Dates: 2022 Nov 16-18
Meeting Location: Basel, Switzerland
ISSN: 1424-7860
Publisher: E M H Swiss Medical Publishers Ltd  
Date Published: 2022-11-14
Start Page: 11S
Language: English
ACCESSION: WOS:000912385900012
PROVIDER: wos
DOI: 10.57187/smw.2022.40034
Notes: Meeting Abstract: 104 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ross Levine
    775 Levine
  2. Richard Patrick Koche
    173 Koche
  3. Li   Yang
    29 Yang